177 related articles for article (PubMed ID: 23266392)
1. Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.
Kohaar I; Porter-Gill P; Lenz P; Fu YP; Mumy A; Tang W; Apolo AB; Rothman N; Baris D; Schned AR; Ylaya K; Schwenn M; Johnson A; Jones M; Kida M; Silverman DT; Hewitt SM; Moore LE; Prokunina-Olsson L
J Natl Cancer Inst; 2013 Jan; 105(1):69-73. PubMed ID: 23266392
[TBL] [Abstract][Full Text] [Related]
2. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.
Fu YP; Kohaar I; Rothman N; Earl J; Figueroa JD; Ye Y; Malats N; Tang W; Liu L; Garcia-Closas M; Muchmore B; Chatterjee N; Tarway M; Kogevinas M; Porter-Gill P; Baris D; Mumy A; Albanes D; Purdue MP; Hutchinson A; Carrato A; Tardón A; Serra C; García-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Diver WR; Gapstur SM; Thun MJ; Virtamo J; Chanock SJ; Fraumeni JF; Silverman DT; Wu X; Real FX; Prokunina-Olsson L
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4974-9. PubMed ID: 22416122
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell antigen: a Jekyll and Hyde molecule?
Saeki N; Gu J; Yoshida T; Wu X
Clin Cancer Res; 2010 Jul; 16(14):3533-8. PubMed ID: 20501618
[TBL] [Abstract][Full Text] [Related]
4. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
Wu X; Ye Y; Kiemeney LA; Sulem P; Rafnar T; Matullo G; Seminara D; Yoshida T; Saeki N; Andrew AS; Dinney CP; Czerniak B; Zhang ZF; Kiltie AE; Bishop DT; Vineis P; Porru S; Buntinx F; Kellen E; Zeegers MP; Kumar R; Rudnai P; Gurzau E; Koppova K; Mayordomo JI; Sanchez M; Saez B; Lindblom A; de Verdier P; Steineck G; Mills GB; Schned A; Guarrera S; Polidoro S; Chang SC; Lin J; Chang DW; Hale KS; Majewski T; Grossman HB; Thorlacius S; Thorsteinsdottir U; Aben KK; Witjes JA; Stefansson K; Amos CI; Karagas MR; Gu J
Nat Genet; 2009 Sep; 41(9):991-5. PubMed ID: 19648920
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in PSCA is associated with bladder cancer susceptibility in a Korean population.
Lee JH; Song HR; Kim HN; Kweon SS; Yun YW; Choi JS; Jung SI; Kwon DD; Kim SH; Choi YD; Shin MH
Asian Pac J Cancer Prev; 2014; 15(20):8901-4. PubMed ID: 25374226
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
[TBL] [Abstract][Full Text] [Related]
8. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
9. Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.
Yang X; Guo Z; Liu Y; Si T; Yu H; Li B; Tian W
Expert Rev Anticancer Ther; 2014 Jan; 14(1):31-7. PubMed ID: 24308679
[TBL] [Abstract][Full Text] [Related]
10. The
Wang XF; Liu DL; Geng L
Genet Test Mol Biomarkers; 2023 Feb; 27(2):44-55. PubMed ID: 36853840
[No Abstract] [Full Text] [Related]
11. The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells.
Chizari M; Fani-Kheshti S; Taeb J; Farajollahi MM; Mohsenzadegan M
Recent Pat Anticancer Drug Discov; 2021; 16(1):73-83. PubMed ID: 33176663
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population.
Wang S; Tang J; Wang M; Yuan L; Zhang Z
Carcinogenesis; 2010 Apr; 31(4):621-4. PubMed ID: 20083643
[TBL] [Abstract][Full Text] [Related]
13. PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population.
Wang S; Wu S; Zhu H; Ding B; Cai Y; Ni J; Wu Q; Meng Q; Zhang X; Zhang C; Li X; Wang M; Chen R; Jin H; Zhang Z
Sci Rep; 2016 Mar; 6():23465. PubMed ID: 27001215
[TBL] [Abstract][Full Text] [Related]
14. MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
Ren J; Wang F; Wei G; Yang Y; Liu Y; Wei M; Huan Y; Larson AC; Zhang Z
PLoS One; 2012; 7(6):e38350. PubMed ID: 22761679
[TBL] [Abstract][Full Text] [Related]
15. Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.
Marra E; Uva P; Viti V; Simonelli V; Dogliotti E; De Rinaldis E; Lahm A; La Monica N; Nicosia A; Ciliberto G; Palombo F
BMC Cancer; 2010 Apr; 10():129. PubMed ID: 20374648
[TBL] [Abstract][Full Text] [Related]
16. An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.
Lepin EJ; Leyton JV; Zhou Y; Olafsen T; Salazar FB; McCabe KE; Hahm S; Marks JD; Reiter RE; Wu AM
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1529-38. PubMed ID: 20354850
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors.
Bahrenberg G; Brauers A; Joost HG; Jakse G
Biochem Biophys Res Commun; 2000 Sep; 275(3):783-8. PubMed ID: 10973799
[TBL] [Abstract][Full Text] [Related]
18. Contribution of prostate stem cell antigen variation rs2294008 to the risk of bladder cancer.
Deng S; Ren ZJ; Jin T; Yang B; Dong Q
Medicine (Baltimore); 2019 Apr; 98(16):e15179. PubMed ID: 31008939
[TBL] [Abstract][Full Text] [Related]
19. PSCA rs2294008 Polymorphism with Increased Risk of Cancer.
Geng P; Li J; Wang N; Ou J; Xie G; Liu C; Zhao X; Xiang L; Liao Y; Liang H
PLoS One; 2015; 10(8):e0136269. PubMed ID: 26308216
[TBL] [Abstract][Full Text] [Related]
20. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population.
Wang M; Bai J; Tan Y; Wang S; Tian Y; Gong W; Zhou Y; Gao Y; Zhou J; Zhang Z
Int J Cancer; 2011 Sep; 129(5):1207-13. PubMed ID: 21064099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
